Rapid antidepressant response after nocturnal TRH administration in patients with bipolar type I and bipolar type II major depression

Journal of Clinical Psychopharmacology

Volumn 25, Issue 4, 2005, Pages 325-330

  Szuba, Martin P ^a   Amsterdam, Jay D ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b The Science Center Philadelphia   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; PROTIRELIN; THYROTROPIN; THYROXINE;

ADULT; ANGER; ANXIETY; ARTICLE; BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; HAMILTON SCALE; HOSTILITY; HUMAN; MAJOR DEPRESSION; MALE; MENTAL DISEASE; MOOD; PRIORITY JOURNAL; PROFILE OF MOOD STATES; RADIOIMMUNOASSAY; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; TREATMENT OUTCOME; YOUNG MANIA RATING SCALE;

ADULT; BIPOLAR DISORDER; CHRONOTHERAPY; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; PSYCHOLOGICAL TESTS; THYROID HORMONES; THYROTROPIN; THYROTROPIN-RELEASING HORMONE; TIME FACTORS; TREATMENT OUTCOME;

EID: 23044445100     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000169037.17884.79     Document Type: Article

References (47)

1. O'Connor D, Gwirtzman H, Loosen PT. Thyroid function in psychiatric disorders. In: Wolkowitz OM, Rothschild AJ, eds. Psychoneuroendocrinology: The Scientific Basis of Clinical Practice. Washington, DC: American Psychiatric Publishing; 2003:361-418.
2. Desiles M, Rips R. Use of potentiation of thyrotrophin releasing hormone (TRH)-induced hyperthermia as a test for screening antidepressants which activate alpha-adrenoceptor systems. Br J Pharmacol. 1981; 74:81-86.
3. Lighten C, Bennett GW, Marsden CA. Increase in levels and ex vivo release of thyrotrophin-releasing hormone (TRH) in specific regions of the CNS of the rat by chronic treatment with antidepressants. Neuropharmacology. 1985;24:401-406.
4. Reny-Palasse V, Rips R. Potentiation by TRH of the effect of imipramine on the forced-swimming test. Br J Pharmacol. 1985;85:463-470.
5. Przegalinski E, Baran L, Siwanowicz J. The effect of repeated treatment with antidepressant drugs on the thyrotropin-releasing hormone (TRH)-induced hyperthermia in mice. J Pharm Pharmacol. 1989;41: 639-641.
6. Reny-Palasse V, Constans M, Rips R. Potentiation by TRH of the effect of antidepressants in the forced-swimming test, involvement of dopaminergic and opioid systems. Br J Pharmacol. 1989;97:197-205.
7. Zimmermann RC, Krahn LE, Klee GG, et al. Prolonged inhibition of presynaptic catecholamine synthesis with alpha-methyl-para-tyrosine attenuates the circadian rhythm of human TSH secretion. J Soc Gynecol Investig. 2001;8:174-178.
8. Gary KA, Sollars PJ, Lexow N, et al. Thyrotropin-releasing hormone phase shifts circadian rhythms in hamsters. NeuroReport. 1996;7: 1631-1641.
9. Gary KA, Winokur A, Douglas SD, et al. Total sleep deprivation and the thyroid axis: effects of sleep and waking activity. Aviat Space Environ Med. 1996;67:513-539.
10. Staner L, Duval F, Calvi-Gries F, et al. Morning and evening TSH response to TRH and sleep EEG disturbances in major depressive disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2001;25: 535-547.
11. Angel Vargas M, Uribe RM, Cisneros M, et al. Thyrotropin-releasing hormone regulates the diurnal variation of pyroglutamyl aminopeptidase II activity in the male rat adenohypophysis. Eur J Endocrinol. 2002;147: 363-369.
12. Prange AJ Jr, Wilson IC, Lara PP, et al. Effects of thyrotropin-releasing hormone in depression. Lancet. 1972;ii:999-1002.
13. Kastin AJ, Ehrensing RH, Schalch DS, et al. Improvement in mental depression with decreased thyrotropin response after administration of thyrotropin-releasing hormone. Lancet. 1972;ii:740-742.
14. Benkert O, Gordon A, Martscleke D. The comparison of thyrotropin releasing hormone, luteinizing hormone-releasing hormone and placebo in depressive patients using a double-blind cross-over technique. Psychopharmacologia. 1974;40:191-198.
15. Itil TM, Patterson CD, Polvan N, et al. Clinical and CNS effects of oral and IV thyrotropin-releasing hormone in depressed patients. Dis Nerv Syst. 1975;36:529-536.
16. Mountjoy CQ, Weller M, Hall R, et al. A double-blind, cross-over sequential trial of oral thyrotropin-releasing hormone in depression. Lancet I. 1974;ii:958-960.
17. Pecknold JC, Ban TA, Lehmann HE, et al. Thyrotropin-releasing hormone in depression: clinical and endocrinological findings. Psychopharmacol Bull. 1976;12:44-48.
18. Amsterdam JD, Winokur A, Caroff S, et al, Antidepressant effect of TRH in patients with primary depression, anorexia nervosa, and normal volunteers. Am J Psychiatry. 1981;138:115-116.
19. Wilson IC, Prange AJ Jr, Lara PP, et al. TRH (lopremone): psychobiological responses of normal women: I. Subjective experiences. Arch Gen Psychiatry. 1973;29:15-21.
20. Wilson IC, Prange AJ Jr, Loosen PT. Psychological and thyroid-stimulating hormone changes after thyrotropin-releasing hormone in normal women: antagonism by pretreatment with thyroid hormones. Psychiatr Res. 1980;2:211-222.
21. Betts TA, Smith J, Pidd S, et al. The effects of thyrotropin-releasing hormone on measures of mood in normal women. Br J Clin Pharmacol. 1976;3:469-473.
22. Winokur A, Amsterdam JD, Mihailovic V, et al. Improvement in ratings of tension after TRH administration in healthy women. Psychoneuro-endocrinology. 1982;7:239-244.
23. Van den Burg W, Van Praag HM, Bos ER, et al. Thyrotropin releasing hormone (TRH) as a possible quick-acting but short-lasting antidepres-sant. Psychol Med. 1975;5:404-412.
24. Ehrensing RH, Kastin AJ, Schalch DS, et al. Affective state and thyrotropin and prolactin response after repeated injection of thyrotropin-releasing hormone in depressed patients. Am J Psychiatry. 1974; 131:714-717.
25. Hollister LE, Berger P, Ogle FL, et al. Protirelin (TRH) in depression. Arch Gen Psychiatry. 1974;31:468-470.
26. Coppen A, Montgomery S, Peet M, et al. Thyrotropin-releasing hormone in the treatment of depression. Lancet. 1974;ii:433-434.
27. Souetre E, Salvati E, Wehr TA, et al. Twenty-four hour profiles of body temperature and plasma TSH in bipolar patients during depression and remission and in normal control subjects. Am J Psychiatry. 1988;145: 1133-1137.
28. Duval F, Macher JP, Mokrani MC. Difference between evening and morning thyrotropin responses to protirelin in major depressive episode. Arch Gen Psychiatry. 1990;47:443-448.
29. Duval F, Mokrani MC, Crocq MA, et al. Influence of thyroid hormones on morning and evening TSH response to TRH in major depression. Biol Psychiatry. 1994;35:926-934.
30. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
31. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for Axis I DSM-IV Disorders-Patient Edition. Washington, DC: American Psychiatric Press; 1994.
32. Frye MA, Gary KA, Marangell LB, et al. CSF thyrotropin-releasing hormone gender difference: implications for neurobiology and treatment of depression. J Neuropsychiatry Clin Neurosci. 1999;11:349-353.
33. Szuba MP, Baxter LR, Fairbanks LA, et al. The effects of partial sleep deprivation on the diurnal variation of mood and motor activity. Biol Psychiatry. 1991;30:817-829.
34. Szuba MP, Baxter LR, Altshuler LL, et al. Lithium sustains the acute antidepressant effects of partial sleep deprivation: preliminary findings. Psychiatry Res. 1994;51:283-295.
35. Young RC, Biggs JT, Ziegler VE, et al. Rating scale for mania-reliability, validity and sensitivity. Br J Psychiatry. 1978;133:429-435.
36. McNair D, Lorr M, Droppelman L. Manual for the Profile of Mood States. San Diego: Educational and Industrial Testing Service; 1971.
37. McNair D, Lorr M, Droppelman L. Manual for the Profile of Mood States. Rev. ed. San Diego: Educational and Industrial Testing Service; 1992.
38. Brady KT, Anton RF. The thyroid axis and desipramine treatment in depression. Biol Psychiatry. 1989;25:703-709.
39. Gendall KA, Joyce PR, Mulder RT, et al. Thyroid indices and response to fluoxetine and nortriptyline in major depression. J Psychopharmacol. 2003;17:431-437.
40. Gyulai L, Bauer M, Bauer MS, et al. Thyroid hypofunction in patients with rapid-cycling bipolar disorder after lithium challenge. Biol Psychiatry. 2003;53:899-905.
41. Prange AJ Jr, Mason GA, Garbutt JC. Thyroid axis syndromes in depression: definitions and interpretations. In: Amsterdam JD, ed. Pharmacotherapy of Depression. New York: Marcell Decker. 1990:35-56.
42. Schopf J, Lemarchand T. Lithium addition in endogenous depressions resistant to tricyclic antidepressants or related drugs: relation to the status of the pituitary-thyroid axis. Pharmacopsychiatry. 1994;27: 198-201.
43. Rao ML, Ruhrmann S. Retey B, et al. Low plasma thyroid indices of depressed patients are attenuated by antidepressant drugs and influence treatment outcome. Pharmacopsychiatry. 1996;29:180-186.
44. Furlong FW, Brown GM, Beeching MF. Thyrotropin-releasing hormone: differential antidepressant and endocrinological effects. Am J Psychiatry. 1976;133:1187-1190.
45. Callahan AM, Frye MA, Marangell LB, et al. Comparative antidepressant effects of intravenous and intrathecal thyrotropin-releasing hormone: confounding effects of tolerance and implications for therapeutics. Biol Psychiatry. 1997;41:264-272.
46. Marangell LB, George MS, Callahan AM, et al. Effects of intrathecal thyrotropin-releasing hormone (protirelin) in refractory depressed patients. Arc Gen Psychiatry. 1997;54:214-222.
47. Nair RMG, Redding TW, Schally AV. Site of inactivation of thyrotropin-releasing hormone by human plasma. Biochemistry. 1971; 10:3621-3624.